ACW 5.13% 3.7¢ actinogen medical limited

Ann: Actinogen presents latest Xanamem data at AD Conference, page-26

  1. 8,515 Posts.
    lightbulb Created with Sketch. 1397
    @csrwin
    Thanks for the link.

    Points I noticed.

    * the main reason that XanaHES didn't continue to 30mg was because full target occupancy was achieved at 20mg

    * funding of future studies wasn't discussed. Nor should it have been; this was a purely scientific presentation

    * although the target occupancy study doesn't complete until Q2, 20mg has already been chosen for MCI

    * at about 14:00 a toilet flushing noise can be distinctly heard. No dogs barking or babies crying that I noticed. YMMV.

    GLTALTH and please keep washing your hands for the foreseeable future

    II
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.002(5.13%)
Mkt cap ! $100.3M
Open High Low Value Volume
3.7¢ 3.9¢ 3.7¢ $145.2K 3.906M

Buyers (Bids)

No. Vol. Price($)
4 227192 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 15085 1
View Market Depth
Last trade - 15.37pm 12/09/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.